Randomized, Double-blind, Placebo-controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke

Completed

Phase N/A Results

Eligibility Criteria

Inclusion Criteria

Aged 16-69, acute ischemic hemispheric stroke within 48 hours of onset.

Exclusion Criteria

Unconsciousness, inability to swallow, rapidly improving signs and symptoms, dependence in activities of daily living prior to stroke, brain stem infarction, complicated migraine, pregnancy, overt renal, hepatic or cardiac failure, severe systemic infection, serious psychiatric disturbance, terminal malignancy.